Federated Hermes’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.23M | Buy |
691,381
+3,598
| +0.5% | +$16.8K | 0.01% | 838 |
|
|
2025
Q1 | $3.78M | Buy |
687,783
+685,906
| +36,543% | +$3.77M | 0.01% | 782 |
|
|
2024
Q4 | $6.36K | Buy |
1,877
+1,696
| +937% | +$5.75K | ﹤0.01% | 1878 |
|
|
2024
Q3 | $516 | Buy |
+181
| New | +$516 | ﹤0.01% | 2000 |
|
|
2023
Q3 | – | Sell |
-44,839
| Closed | -$117K | – | 2213 |
|
|
2023
Q2 | $117K | Buy |
+44,839
| New | +$117K | ﹤0.01% | 1606 |
|
|
2021
Q2 | – | Sell |
-300,000
| Closed | -$1.35M | – | 2349 |
|
|
2021
Q1 | $1.35M | Hold |
300,000
| – | – | ﹤0.01% | 1255 |
|
|
2020
Q4 | $1.48M | Hold |
300,000
| – | – | ﹤0.01% | 1180 |
|
|
2020
Q3 | $1.78M | Hold |
300,000
| – | – | ﹤0.01% | 1040 |
|
|
2020
Q2 | $798K | Hold |
300,000
| – | – | ﹤0.01% | 1325 |
|
|
2020
Q1 | $585K | Hold |
300,000
| – | – | ﹤0.01% | 1331 |
|
|
2019
Q4 | $2.12M | Hold |
300,000
| – | – | ﹤0.01% | 1010 |
|
|
2019
Q3 | $2.95M | Hold |
300,000
| – | – | 0.01% | 913 |
|
|
2019
Q2 | $3.43M | Hold |
300,000
| – | – | 0.01% | 900 |
|
|
2019
Q1 | $3.01M | Hold |
300,000
| – | – | 0.01% | 915 |
|
|
2018
Q4 | $5.1M | Hold |
300,000
| – | – | 0.01% | 729 |
|
|
2018
Q3 | $5.27M | Hold |
300,000
| – | – | 0.01% | 789 |
|
|
2018
Q2 | $5.69M | Buy |
+300,000
| New | +$5.69M | 0.02% | 640 |
|